Global Acute External Ventricular Drain Market Size study, by Patient Type (Pediatric, Adult) by Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Non-traumatic Hydrocephalus conditions), and Regional Forecasts

Global Acute External Ventricular Drain Market Size study, by Patient Type (Pediatric, Adult) by Application (Traumatic Brain Injury, Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Other Non-traumatic Hydrocephalus conditions), and Regional Forecasts 2022-2028

Global Acute External Ventricular Drain Market is valued approximately USD 218.71 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.91% over the forecast period 2022-2028. External ventricular drain is a temporary system that allows the drainage of Cerebral Spinal Fluid (CSF) from the ventricles to an external closed system. The increasing prevalence of neurological disorders and rising technological advancements in the healthcare sector as well as strategic initiatives from leading market players are key drivers accelerating the Market growth. According to World Health Organization (WHO) estimates – as of 2020, around 15 Million people worldwide suffer from stroke and out of which 5 million people die and 5 Million people get paralyzed, becoming a burden on the family. Moreover, leading market players are working towards the expansion of production capacity to leverage the growing adoption of Acute External Ventricular Drain Devices. As in October 2021, Germany based Raumedic AG announced expansion of its clean room manufacturing facilities at its the U.S. headquarters in Mills River, North Carolina. The new 3,500-square-foot clean room would be operational by February 2022. Also, increasing awareness among people towards hemorrhage disease and the rising healthcare sector in emerging markets would create lucrative growth opportunities for the market during the forecast period. However, the high cost of Acute External Ventricular Drain technological treatment impedes the market growth throughout the forecast period of 2022-2028.

The key regions considered for the Global Acute External Ventricular Drain Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region in terms of market share due to rising incidences of neurological conditions and favorable government initiatives in the region. The Asia Pacific is estimated to grow significantly during the forecast period. This is because of the rising awareness among individuals towards neurological disorders as well as rising healthcare infrastructure in the region.

Major market players included in this report are:
Medtronic
Integra LifeSciences Corporation
Natus Medical Incorporated
Fuji Systems
Spiegelberg GmbH
SOPHYSA
Neuromedex
Dispomedica GmbH
Möller Medical GmbH
B. Braun Melsungen AG
The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Patient Type:
Pediatric
Adult
By Application:
Traumatic Brain Injury
Subarachnoid Hemorrhage
Intracerebral Hemorrhage
Other Non-traumatic Hydrocephalus conditions

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Acute External Ventricular Drain Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Companies Mentioned

Medtronic
Integra LifeSciences Corporation
Natus Medical Incorporated
Fuji Systems
Spiegelberg GmbH
SOPHYSA
Neuromedex
Dispomedica GmbH
Möller Medical GmbH
B. Braun Melsungen AG

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.